Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2019 | Pages:
72 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)
The India malaria diagnostics market size is expected to reach USD 27.5 million by 2026, expanding at a CAGR of 5.4%, according to a new report by Grand View Research, Inc. Key drivers of the market include rising demand for malaria diagnostics, introduction of novel diagnostic techniques, and increasing prevalence of the disease in the nation. Increasing initiatives undertaken by the government is anticipated to propel market growth during the forecast period. The government of India has been committed to achieving malaria free recognition by 2027. Highest prevalence of the disease is typically seen across states such as Arunachal Pradesh, Jharkhand, Maharashtra, Tripura, Madhya Pradesh, Dadar & Nagar Haveli, Meghalaya, Mizoram, and Odisha. The Micro Strategic Plan for Malaria Elimination in the State of Punjab, India (2018-2020) was developed by the National Vector Borne Disease Control Program and the State Government of Punjab in collaboration with WHO Country Office of India and National Vector Borne Disease Control Program, Delhi. In alignment with the National Strategic Plan for Malaria Elimination (2017-2022), the Government of Punjab launched a state-specific Strategic Action Plan (SAP) to eliminate the disease. The goal of this SAP is to achieve zero malaria transmission by 2020 and ensure prevention of reintroduction of the disease after 2020. Some of the objectives of SAP in Punjab are, reduction of disease incidence to zero indigenous cases to achieve malaria free status in the state, reduction in the number of active disease foci to zero level, and maintaining zero deaths caused by malaria. Thus, rise in such initiatives by the government to curb the disease is anticipated to fuel market growth. Rising demand for diagnostic tools in malaria-endemic countries such as India, is one of the major factors accelerating market growth. According to the World Malaria Report published by WHO, India contributed to around 4% of the total cases and 48% of Plasmodium vivax infections globally. According to a research study published by the National Center for Biotechnology Information (NCBI), almost 70% of malaria cases were reported by five states, namely, Chhattisgarh, Madhya Pradesh, Odisha, Jharkhand, and Maharashtra. Hilly and tribal areas of the country such as Meghalaya, Nagaland, and Mizoram also exhibit high prevalence of the disease. These facts are indicative of the chronic burden of the disease in endemic countries, making it an urgent health priority in these regions. Increasing initiatives undertaken by market players to reduce disease prevalence is also one of the major factors driving the market. For instance, Abbott Laboratories and a non-profit group called "Malaria No More" are providing the Odisha government with one million RDTs. In addition, Abbott Laboratories is contributing USD 750,000 to the non-profit group, facilitating the government of Odisha's Vector Borne Disease Control Program. Such initiatives are expected to facilitate the development of new and advanced diagnostic technologies and product launches. Further key findings from the report suggest: • The microscopy technology segment is expected to be the largest in 2018 owing to its high adoption rate and factors such as accurate diagnosis and cost effectiveness • Molecular diagnostic tests are anticipated to be the fastest during the forecast period as they are highly sensitive, accurate, and capable of detecting low parasite count • The hospitals & clinics segment held the largest market share in 2018 as such healthcare facilities act as primary service providers for diagnosis and treatment. Majority of the population relies on these long-term facilities for diagnosis, treatment, and management of diseases • Blood banks are expected to witness the fastest growth during the forecast period as donated blood is screened for a wide range of diseases such as hepatitis, HIV, and STDs as well as other infectious diseases. Moreover, a rise in the number of surgical procedures has been reported in India, which can be attributed to the increase in incidence of severe chronic diseases and accidents, which has created a rise in demand for blood donations. • Key players include in the India malaria diagnostics market are Abbott Laboratories; Siemens Healthineers; Bio-Rad Laboratories; Beckman Coulter, Inc.; Access Bio, Inc.; Premier Medical Corporation Pvt. Ltd.; Olympus Corporation; Nikon Corporation; J. Mitra & Co. Pvt. Ltd.; Tulip Diagnostics Ltd.; and Microgene Diagnostic Systems Pvt. Ltd.
Table of Content
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Technology
1.1.2 End Use
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr's Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.3.5.1 Information or Data Analysis
1.3.6 Data Analysis Models
1.4 Market Formulation & Validation
1.5 Model Details
1.5.1 Commodity Flow Analysis (Model 1)
1.5.1.1 Approach 1: Commodity Flow Approach
1.5.2 Volume Price Analysis (Model 2)
1.5.2.1 Approach 2: Volume Price Analysis
1.6 List of Secondary Sources
1.7 List of Abbreviations
1.8 Objectives
1.8.1 Objective 1:
1.8.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
Chapter 3 India Malaria Diagnostics Market Variables,
3.1 India Malaria Diagnostics Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Increasing demand for malaria diagnostic tools in India
3.1.1.2 Development of technologically advanced and efficient diagnostics
3.1.1.3 Rising investment by government bodies, market players, and private investors to curb prevalence of malaria
3.1.1.4 Inadequate healthcare infrastructure
3.1.2 Market Restraint Analysis
3.1.2.1 Ban on antibody-based rapid diagnostic tests
3.1.3 Market Challenge Analysis
3.1.3.1 Shortage of skilled healthcare professionals
3.2 India Malaria Diagnostics: Market Analysis Tools
3.2.1 Industry Analysis - Porter's
3.2.2 India Malaria Diagnostics - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
Chapter 4 India Malaria Diagnostics Market: Segment Analysis, by Technology, 2015 - 2026 (USD Million)
4.1 Definitions & Scope
4.2 India Malaria Diagnostics Market Share Analysis, 2018 & 2026
4.3 Segment Dashboard
4.4 India Malaria Diagnostics Market Size & Forecasts and Trend Analysis, by Antibody Type, 2015 to 2026
4.4.1 Microscopy
4.4.1.1 Microscopy market estimates and forecasts, 2015 - 2026 (USD Million)
4.4.2 Rapid Diagnostic Tests (Rdt)
4.4.2.1 RDTs market estimates and forecasts, 2015 - 2026 (USD Million)
4.4.3 Molecular Diagnostic Tests
4.4.3.1 Molecular diagnostic tests market estimates and forecasts, 2015 - 2026 (USD Million)
4.4.3.2 Conventional PCR market estimates and forecasts, 2015 - 2026 (USD Million)
4.4.3.3 Real-Time PCR (qPCR or quantitative PCR) market estimates and forecasts, 2015 - 2026 (USD Million)
Chapter 5 India Malaria Diagnostics Market: Segment Analysis, by End Use, 2015 - 2026 (USD Million)
5.1 Definitions & Scope
5.2 India Malaria Diagnostics Market Share Analysis, 2018 & 2026
5.3 Segment Dashboard
5.4 India Malaria Diagnostics Market Size & Forecasts and Trend Analysis, by end Use, 2015 to 2026
5.4.1 Hospitals & Clinics
5.4.1.1 Hospitals & Clinics market estimates and forecasts, 2015 - 2026 (USD Million)
5.4.2 Diagnostic Laboratories
5.4.2.1 Diagnostic Laboratories market estimates and forecasts, 2015 - 2026 (USD Million)
5.4.3 Blood Banks
5.4.3.1 Blood banks market estimates and forecasts, 2015 - 2026 (USD Million)
5.4.4 Academic And Research Institutes
5.4.4.1 Academic and research institutes market estimates and forecasts, 2015 - 2026 (USD Million)
Chapter 6 India Malaria Diagnostics Market, Competitive Landscape
6.1 Company Profiles
6.1.1 ABBOTT LABORATORIES
6.1.1.1 Company overview
6.1.1.2 Financial Performance
6.1.1.3 Product benchmarking
6.1.1.4 Strategic initiatives
6.1.2 SIEMENS HEALTHINEERS
6.1.2.1 Company overview
6.1.2.2 Financial Performance
6.1.2.3 Product benchmarking
6.1.2.4 Strategic initiatives
6.1.3 BIO-RAD LABORATORIES, INC.
6.1.3.1 Company overview
6.1.3.2 Financial Performance
6.1.3.3 Product benchmarking
6.1.4 BECKMAN COULTER, INC.
6.1.4.1 Company overview
6.1.4.2 Financial Performance
6.1.4.3 Product benchmarking
6.1.4.4 Strategic initiatives
6.1.5 ACCESS BIO, INC.
6.1.5.1 Company overview
6.1.5.2 Product benchmarking
6.1.5.3 Strategic initiatives
6.1.6 PREMIER MEDICAL CORPORATION PVT LTD.
6.1.6.1 Company overview
6.1.6.2 Product benchmarking
6.1.7 OLYMPUS CORPORATION
6.1.7.1 Company overview
6.1.7.2 Financial Performance
6.1.7.3 Product benchmarking
6.1.8 NIKON CORPORATION
6.1.8.1 Company overview
6.1.8.2 Financial Performance
6.1.8.3 Product benchmarking
6.1.8.4 Strategic initiatives
6.1.9 J MITRA & CO. PVT. LTD
6.1.9.1 Company overview
6.1.9.2 Product benchmarking
6.1.9.3 Strategic initiative
6.1.10 TULIP DIAGNOSTICS (P) LTD.
6.1.10.1 Company overview
6.1.10.2 Product benchmarking
6.1.11 MICROGENE DIAGNOSTIC SYSTEMS PVT. LTD.
6.1.11.1 Company overview
6.1.11.2 Product benchmarking
Chapter 7 India Malaria Diagnostics Market, Test Volume Analysis
7.1 Malaria Diagnostic Products, RTDs Volume Analysis
Chapter 8 India Malaria Diagnostics Market, Pricing Analysis
8.1 Malaria Diagnostic Products, Pricing Analysis
Chapter 9 India Malaria Diagnostics Market, Market Share Analysis
9.1 India Malaria Diagnsotics Market Share Analysis
List of Tables Table 1 List of secondary sources Table 2 List of abbreviation Table 3 India Malaria Diagnostic Test Volume Analysis, 2015 - 2018 (Million units) Table 4 India Malaria Diagnostic Pricing Analysis, 2015 - 2018 (USD)
List of Figures Fig. 1 Market research process Fig. 2 Data triangulation techniques Fig. 3 Primary research pattern Fig. 4 Market research approaches Fig. 5 Value-chain-based sizing & forecasting Fig. 6 QFD modeling for market share assessment Fig. 7 Market formulation & validation Fig. 8 Commodity flow analysis Fig. 9 Volume price analysis Fig. 10 India Malaria Diagnostics Market Snapshot (2018) Fig. 11 India malaria diagnostics market driver impact Fig. 12 India malaria diagnostics market restraint impact Fig. 13 India malaria diagnostics market challenge impact Fig. 14 Porter's five force analysis Fig. 15 SWOT analysis, by factor (political & legal, economic and technological) Fig. 16 India malaria diagnostics market share, by technology, 2018 & 2026 (%) Fig. 17 India Malaria Diagnostics Market: Segment Dashboard Fig. 18 Microscopy market, 2015 - 2026 (USD Million) Fig. 19 RDTs market, 2015 - 2026 (USD Million) Fig. 20 Molecular diagnostic tests market, 2015 - 2026 (USD Million) Fig. 21 Conventional PCR market, 2015 - 2026 (USD Million) Fig. 22 Real-time PCR (qPCR or quantitative PCR) market, 2015 - 2026 (USD Million) Fig. 23 India Malaria Diagnostics Market Share, by End Use, 2018 & 2026 (%) Fig. 24 India Malaria Diagnostics Market: Segment Dashboard Fig. 25 Hospitals & clinics market, 2015 - 2026 (USD Million) Fig. 26 Diagnostic laboratories market, 2015 - 2026 (USD Million) Fig. 27 Blood banks market, 2015 - 2026 (USD Million) Fig. 28 Blood banks market, 2015 - 2026 (USD Million) Fig. 29 Top 6 Market Players, Market Share Analysis, 2018
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
